Lydia Benitez

University of Michigan

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Anastasia Wasylyshyn

University of Michigan

UNITED STATES

View details

Marcus Geer

University of Michigan

UNITED STATES

View details

Shawn Griffin

Health Sciences Assistant Clinical Professor

University of California, Irvine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lydia Benitez

Research Interests

Explore related searches

Contact this professor

Articles (20)

It’s “blin” a long time coming: the rise of blinatumomab in Philadelphia chromosome-negative acute lymphoblastic leukemia

Multicenter Retrospective Evaluation of Treatment for High-Risk Acute Promyelocytic Leukemia: Real-World Outcomes From the HERO Consortium

Impact of Chemotherapy Educational Videos for Patients with Acute Myeloid Leukemia

Therapeutic outcomes of patients with acute erythroid leukemia treated with hypomethylating agents

Time to complete oncology pharmacist tasks: A joint opinion of the Hematology/Oncology Pharmacy Association and American College of Clinical Pharmacy's Hematology/Oncology Practice and Research Network

Real-world outcomes with immunosuppressive therapy for aplastic anemia in patients treated at the University of Michigan

Tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax and hypomethylating agents with or without dose ramp-up

Impact of number of lumens in central-venous catheters on central-line bloodstream infection (CLABSI) and venous thromboembolism (VTE) risk in patients with acute leukemia

Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia

Multicenter Retrospective Evaluation of Treatment of High-Risk Acute Promyelocytic Leukemia (APL): Results from the Hematology Research Outcomes (HERO) Consortium

Evaluating the efficacy and toxicity of dose adjusted pegylated L-asparaginase in combination with therapeutic drug monitoring

Multicenter comparison of first salvage chemotherapy versus novel therapy regimens in adult relapsed/refractory acute lymphoblastic leukemia

Oncology stewardship in acute myeloid leukemia

Real world outcomes in patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation–A single institution experience

Real world use of FLT3 inhibitors for treatment of FLT3+ acute myeloid leukemia (AML): A single center, propensity-score matched, retrospective cohort study

Solving coagulation conundrums: comparing prophylaxis strategies in adult patients receiving PEG-asparaginase

Invasive Fungal Disease in Patients with Newly Diagnosed Acute Myeloid Leukemia

Clinical availability of atra for patients with suspected acute promyelocytic leukemia: Why guidelines may not be followed

Comparative pharmacokinetic analysis of the blood-brain barrier penetration of dasatinib and ponatinib in mice

Evaluating the Role of Novel Oncology Agents: Oncology Stewardship in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Collaborators (3)

Anastasia Wasylyshyn

Marcus Geer

Shawn Griffin

Make your next move.